Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study. (2022)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/jha2.537
PubMed Identifier: 36467809
Publication URI: http://europepmc.org/abstract/MED/36467809
Type: Journal Article/Review
Volume: 3
Parent Publication: EJHaem
Issue: 4
ISSN: 2688-6146